_id
6911be24ccc777a4e85d62a6
Ticker
GNFT
Name
Genfit S.A.
Exchange
NASDAQ
Address
Parc EurasantE, Loos, France, 59120
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.genfit.com
Description
Genfit S.A., a late-stage biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company develops Elafibranor, which is in Phase III clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagnosis of nonalcoholic steatohepatitis (NASH) and fibrosis; VS-01 for the treatment of Urea Cycle Disorder (UCD) and Organic Acidemia Disorder (OAD); GNS561, which is in Phase 1b/2a trial to treat patients with cholangiocarcinoma (CCA); VS-01-ACLF and Nitazoxanide (NTZ), which is in Phase 1 trial to treat acute-on-chronic liver failure, as well as VS-02-HE, which is in preclinical trial for the treatment of Reduction of Hyperammonemia and the Stabilization of Blood Ammonia; CML-022; SRT-015, an ASK1 inhibitor targets the inhibition of cellular apoptosis, inflammation, and fibrosis. The company has a licensing agreement with Labcorp for the commercialization of NASHnext, a blood-based molecular diagnostic test; and Genoscience Pharma to develop and commercialize the investigational treatment GNS561 for CCA. The company was incorporated in 1999 and is headquartered in Loos, France.
Last Close
4.7
Volume
2027
Current Price
5.3
Change
0.62
Last Updated
2025-11-30T19:28:42.816Z
Image
-
Ipo Date
2019-03-27T00:00:00.000Z
Market Cap
244433360
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.8996999999999999
Sentiment Sources
10
Rating
5
Target Price
7.3857
Strong Buy
1
Buy
0
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-06-30
Revenue
35535000
Cost Of Revenue
962000
Gross Profit
35535000
Operating Expenses
35459000
Operating Income
76000
Interest Expense
-
Pretax Income
-10102000
Net Income
-9956000
Eps
-0.19998069692148035
Dividends Per Share
-
Shares Outstanding
50002896
Income Tax Expense
-2176000
EBITDA
955000
Operating Margin
0.21387364570142112
Total Other Income Expense Net
-10178000
Cash
107511000
Short Term Investments
-
Receivables
36875000
Inventories
4000
Total Current Assets
155429000
Property Plant Equipment
7905000
Total Assets
216683000
Payables
14011000
Short Term Debt
17641000
Long Term Debt
1218000
Total Liabilities
164211000
Equity
52472000
Depreciation
897000
Change In Working Capital
-37840000
Cash From Operations
-30102000
Capital Expenditures
1054000
Cash From Investing
-3219000
Cash From Financing
59287000
Net Change In Cash
25723000
PE
-
PB
5.028576507470651
ROE
-18.973928952584235
ROA
-4.5947305510815335
FCF
-31156000
Fcf Percent
-0.8767693822991417
Piotroski FScore
0
Health Score
11
Deep Value Investing Score
2.5
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
3
Growth Investing Score
3
Momentum Investing Score
5
Net Net Investing Score
1.5
Quality Investing Score
1
Value Investing Score
1.5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
35535000
Quarters > 0 > income Statement > cost Of Revenue
962000
Quarters > 0 > income Statement > gross Profit
35535000
Quarters > 0 > income Statement > operating Expenses
35459000
Quarters > 0 > income Statement > operating Income
76000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-10102000
Quarters > 0 > income Statement > net Income
-9956000
Quarters > 0 > income Statement > eps
-0.19998069692148035
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
49784805
Quarters > 0 > income Statement > income Tax Expense
-2176000
Quarters > 0 > income Statement > EBITDA
955000
Quarters > 0 > income Statement > operating Margin
0.21387364570142112
Quarters > 0 > income Statement > total Other Income Expense Net
-10178000
Quarters > 0 > balance Sheet > cash
107511000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
36875000
Quarters > 0 > balance Sheet > inventories
4000
Quarters > 0 > balance Sheet > total Current Assets
155429000
Quarters > 0 > balance Sheet > property Plant Equipment
7905000
Quarters > 0 > balance Sheet > total Assets
216683000
Quarters > 0 > balance Sheet > payables
14011000
Quarters > 0 > balance Sheet > short Term Debt
17641000
Quarters > 0 > balance Sheet > long Term Debt
1218000
Quarters > 0 > balance Sheet > total Liabilities
164211000
Quarters > 0 > balance Sheet > equity
52472000
Quarters > 0 > cash Flow > net Income
-9956000
Quarters > 0 > cash Flow > depreciation
897000
Quarters > 0 > cash Flow > change In Working Capital
-37840000
Quarters > 0 > cash Flow > cash From Operations
-30102000
Quarters > 0 > cash Flow > capital Expenditures
1054000
Quarters > 0 > cash Flow > cash From Investing
-3219000
Quarters > 0 > cash Flow > cash From Financing
59287000
Quarters > 0 > cash Flow > net Change In Cash
25723000
Quarters > 0 > ratios > PE
-0.19998069692148035
Quarters > 0 > ratios > PB
5.028576507470651
Quarters > 0 > ratios > ROE
-18.973928952584235
Quarters > 0 > ratios > ROA
-4.5947305510815335
Quarters > 0 > ratios > FCF
-31156000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-0.8767693822991417
Quarters > 0 > health Score
11
Quarters > 1 > quarter
2025-03-31
Quarters > 1 > income Statement > revenue
5900000
Quarters > 1 > income Statement > cost Of Revenue
-563000
Quarters > 1 > income Statement > gross Profit
6463000
Quarters > 1 > income Statement > operating Expenses
37531000
Quarters > 1 > income Statement > operating Income
-27941000
Quarters > 1 > income Statement > interest Expense
2396000
Quarters > 1 > income Statement > pretax Income
-28502000
Quarters > 1 > income Statement > net Income
-28804000
Quarters > 1 > income Statement > eps
-0.5799999995972781
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
49662069
Quarters > 1 > income Statement > income Tax Expense
302000
Quarters > 1 > income Statement > EBITDA
-24212000
Quarters > 1 > income Statement > operating Margin
-473.5762711864407
Quarters > 1 > income Statement > total Other Income Expense Net
-562000
Quarters > 1 > balance Sheet > cash
81788000
Quarters > 1 > balance Sheet > short Term Investments
1181000
Quarters > 1 > balance Sheet > receivables
7564000
Quarters > 1 > balance Sheet > inventories
4000
Quarters > 1 > balance Sheet > total Current Assets
92766000
Quarters > 1 > balance Sheet > property Plant Equipment
7595000
Quarters > 1 > balance Sheet > total Assets
151424000
Quarters > 1 > balance Sheet > payables
18387000
Quarters > 1 > balance Sheet > short Term Debt
56581000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
82200000
Quarters > 1 > balance Sheet > equity
69224000
Quarters > 1 > cash Flow > net Income
-28804000
Quarters > 1 > cash Flow > depreciation
861000
Quarters > 1 > cash Flow > change In Working Capital
53419000
Quarters > 1 > cash Flow > cash From Operations
26925000
Quarters > 1 > cash Flow > capital Expenditures
242000
Quarters > 1 > cash Flow > cash From Investing
-352000
Quarters > 1 > cash Flow > cash From Financing
-6535000
Quarters > 1 > cash Flow > net Change In Cash
-61645000
Quarters > 1 > ratios > PE
-0.5799999995972781
Quarters > 1 > ratios > PB
3.802279060730382
Quarters > 1 > ratios > ROE
-41.60984629608228
Quarters > 1 > ratios > ROA
-19.022083685545223
Quarters > 1 > ratios > FCF
26683000
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
4.522542372881356
Quarters > 1 > health Score
39
Quarters > 2 > quarter
2024-12-31
Quarters > 2 > income Statement > revenue
8029000
Quarters > 2 > income Statement > cost Of Revenue
8029000
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
38650000
Quarters > 2 > income Statement > operating Income
-31482000
Quarters > 2 > income Statement > interest Expense
2396000
Quarters > 2 > income Statement > pretax Income
-28502000
Quarters > 2 > income Statement > net Income
-28804000
Quarters > 2 > income Statement > eps
-0.5799999995972781
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
49662069
Quarters > 2 > income Statement > income Tax Expense
302000
Quarters > 2 > income Statement > EBITDA
-24212000
Quarters > 2 > income Statement > operating Margin
-392.1036243616889
Quarters > 2 > income Statement > total Other Income Expense Net
2980000
Quarters > 2 > balance Sheet > cash
81788000
Quarters > 2 > balance Sheet > short Term Investments
1181000
Quarters > 2 > balance Sheet > receivables
7564000
Quarters > 2 > balance Sheet > inventories
4000
Quarters > 2 > balance Sheet > total Current Assets
92766000
Quarters > 2 > balance Sheet > property Plant Equipment
7595000
Quarters > 2 > balance Sheet > total Assets
151424000
Quarters > 2 > balance Sheet > payables
18387000
Quarters > 2 > balance Sheet > short Term Debt
55436000
Quarters > 2 > balance Sheet > long Term Debt
1637000
Quarters > 2 > balance Sheet > total Liabilities
82200000
Quarters > 2 > balance Sheet > equity
69224000
Quarters > 2 > cash Flow > net Income
-28804000
Quarters > 2 > cash Flow > depreciation
861000
Quarters > 2 > cash Flow > change In Working Capital
53419000
Quarters > 2 > cash Flow > cash From Operations
26925000
Quarters > 2 > cash Flow > capital Expenditures
242000
Quarters > 2 > cash Flow > cash From Investing
-352000
Quarters > 2 > cash Flow > cash From Financing
-6535000
Quarters > 2 > cash Flow > net Change In Cash
-
Quarters > 2 > ratios > PE
-0.5799999995972781
Quarters > 2 > ratios > PB
3.802279060730382
Quarters > 2 > ratios > ROE
-41.60984629608228
Quarters > 2 > ratios > ROA
-19.022083685545223
Quarters > 2 > ratios > FCF
26683000
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
3.323327936231162
Quarters > 2 > health Score
39
Quarters > 3 > quarter
2024-06-30
Quarters > 3 > income Statement > revenue
61102000
Quarters > 3 > income Statement > cost Of Revenue
863000
Quarters > 3 > income Statement > gross Profit
61102000
Quarters > 3 > income Statement > operating Expenses
29880000
Quarters > 3 > income Statement > operating Income
31222000
Quarters > 3 > income Statement > interest Expense
2378000
Quarters > 3 > income Statement > pretax Income
30350000
Quarters > 3 > income Statement > net Income
30311000
Quarters > 3 > income Statement > eps
0.5021452125230917
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
60363017
Quarters > 3 > income Statement > income Tax Expense
39000
Quarters > 3 > income Statement > EBITDA
32008000
Quarters > 3 > income Statement > operating Margin
51.09816372622827
Quarters > 3 > income Statement > total Other Income Expense Net
-872000
Quarters > 3 > balance Sheet > cash
61645000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
71043000
Quarters > 3 > balance Sheet > inventories
4000
Quarters > 3 > balance Sheet > total Current Assets
136384000
Quarters > 3 > balance Sheet > property Plant Equipment
8059000
Quarters > 3 > balance Sheet > total Assets
194777000
Quarters > 3 > balance Sheet > payables
8039000
Quarters > 3 > balance Sheet > short Term Debt
8018000
Quarters > 3 > balance Sheet > long Term Debt
55301000
Quarters > 3 > balance Sheet > total Liabilities
97414000
Quarters > 3 > balance Sheet > equity
97363000
Quarters > 3 > cash Flow > net Income
30311000
Quarters > 3 > cash Flow > depreciation
863000
Quarters > 3 > cash Flow > change In Working Capital
-39413000
Quarters > 3 > cash Flow > cash From Operations
-11187000
Quarters > 3 > cash Flow > capital Expenditures
737000
Quarters > 3 > cash Flow > cash From Investing
-687000
Quarters > 3 > cash Flow > cash From Financing
-4225000
Quarters > 3 > cash Flow > net Change In Cash
61645000
Quarters > 3 > ratios > PE
0.5021452125230917
Quarters > 3 > ratios > PB
3.285888788348757
Quarters > 3 > ratios > ROE
31.131949508540206
Quarters > 3 > ratios > ROA
15.5618989921808
Quarters > 3 > ratios > FCF
-11924000
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
-0.19514909495597527
Quarters > 3 > health Score
59
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
67002000
Annuals > 0 > income Statement > cost Of Revenue
300000
Annuals > 0 > income Statement > gross Profit
66702000
Annuals > 0 > income Statement > operating Expenses
63421000
Annuals > 0 > income Statement > operating Income
3281000
Annuals > 0 > income Statement > interest Expense
4782000
Annuals > 0 > income Statement > pretax Income
1847000
Annuals > 0 > income Statement > net Income
1507000
Annuals > 0 > income Statement > eps
0.030000000199071
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
50233333
Annuals > 0 > income Statement > income Tax Expense
340000
Annuals > 0 > income Statement > EBITDA
8345000
Annuals > 0 > income Statement > operating Margin
4.896868750186561
Annuals > 0 > income Statement > total Other Income Expense Net
-1434000
Annuals > 0 > balance Sheet > cash
81788000
Annuals > 0 > balance Sheet > short Term Investments
1181000
Annuals > 0 > balance Sheet > receivables
7564000
Annuals > 0 > balance Sheet > inventories
4000
Annuals > 0 > balance Sheet > total Current Assets
92766000
Annuals > 0 > balance Sheet > property Plant Equipment
7595000
Annuals > 0 > balance Sheet > total Assets
151424000
Annuals > 0 > balance Sheet > payables
18387000
Annuals > 0 > balance Sheet > short Term Debt
56581000
Annuals > 0 > balance Sheet > long Term Debt
1637000
Annuals > 0 > balance Sheet > total Liabilities
82200000
Annuals > 0 > balance Sheet > equity
69224000
Annuals > 0 > cash Flow > net Income
1507000
Annuals > 0 > cash Flow > depreciation
1724000
Annuals > 0 > cash Flow > change In Working Capital
8434000
Annuals > 0 > cash Flow > cash From Operations
15549000
Annuals > 0 > cash Flow > capital Expenditures
979000
Annuals > 0 > cash Flow > cash From Investing
-1039000
Annuals > 0 > cash Flow > cash From Financing
-10570000
Annuals > 0 > cash Flow > net Change In Cash
3999000
Annuals > 0 > ratios > PE
0.030000000199071
Annuals > 0 > ratios > PB
3.846016770195308
Annuals > 0 > ratios > ROE
2.1769906390847105
Annuals > 0 > ratios > ROA
0.9952187235841082
Annuals > 0 > ratios > FCF
14570000
Annuals > 0 > ratios > Piotroski FScore
4
Annuals > 0 > ratios > fcf Percent
0.2174561953374526
Annuals > 0 > health Score
57
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
28565000
Annuals > 1 > income Statement > cost Of Revenue
341000
Annuals > 1 > income Statement > gross Profit
28224000
Annuals > 1 > income Statement > operating Expenses
54804000
Annuals > 1 > income Statement > operating Income
-26580000
Annuals > 1 > income Statement > interest Expense
4648000
Annuals > 1 > income Statement > pretax Income
-28514000
Annuals > 1 > income Statement > net Income
-28894000
Annuals > 1 > income Statement > eps
-0.581365600713703
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
49700223
Annuals > 1 > income Statement > income Tax Expense
380000
Annuals > 1 > income Statement > EBITDA
-22236000
Annuals > 1 > income Statement > operating Margin
-93.05093646070365
Annuals > 1 > income Statement > total Other Income Expense Net
-1934000
Annuals > 1 > balance Sheet > cash
77789000
Annuals > 1 > balance Sheet > short Term Investments
1000
Annuals > 1 > balance Sheet > receivables
32707000
Annuals > 1 > balance Sheet > inventories
4000
Annuals > 1 > balance Sheet > total Current Assets
113115000
Annuals > 1 > balance Sheet > property Plant Equipment
7872000
Annuals > 1 > balance Sheet > total Assets
173872000
Annuals > 1 > balance Sheet > payables
10448000
Annuals > 1 > balance Sheet > short Term Debt
7925000
Annuals > 1 > balance Sheet > long Term Debt
57445000
Annuals > 1 > balance Sheet > total Liabilities
105921000
Annuals > 1 > balance Sheet > equity
67951000
Annuals > 1 > cash Flow > net Income
-28894000
Annuals > 1 > cash Flow > depreciation
1654000
Annuals > 1 > cash Flow > change In Working Capital
-27815000
Annuals > 1 > cash Flow > cash From Operations
-55429000
Annuals > 1 > cash Flow > capital Expenditures
2488000
Annuals > 1 > cash Flow > cash From Investing
2234000
Annuals > 1 > cash Flow > cash From Financing
-5098000
Annuals > 1 > cash Flow > net Change In Cash
-58212000
Annuals > 1 > ratios > PE
-0.581365600713703
Annuals > 1 > ratios > PB
3.8764872025430086
Annuals > 1 > ratios > ROE
-42.52181719179997
Annuals > 1 > ratios > ROA
-16.61797184135456
Annuals > 1 > ratios > FCF
-57917000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-2.0275511990197796
Annuals > 1 > health Score
20
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
20195000
Annuals > 2 > income Statement > cost Of Revenue
248000
Annuals > 2 > income Statement > gross Profit
19947000
Annuals > 2 > income Statement > operating Expenses
47496000
Annuals > 2 > income Statement > operating Income
-27289000
Annuals > 2 > income Statement > interest Expense
4410000
Annuals > 2 > income Statement > pretax Income
-23836000
Annuals > 2 > income Statement > net Income
-23720000
Annuals > 2 > income Statement > eps
-0.4775140025143166
Annuals > 2 > income Statement > dividends Per Share
0
Annuals > 2 > income Statement > shares Outstanding
49673936
Annuals > 2 > income Statement > income Tax Expense
-116000
Annuals > 2 > income Statement > EBITDA
-25805000
Annuals > 2 > income Statement > operating Margin
-135.127506808616
Annuals > 2 > income Statement > total Other Income Expense Net
3454000
Annuals > 2 > balance Sheet > cash
136001000
Annuals > 2 > balance Sheet > short Term Investments
4550000
Annuals > 2 > balance Sheet > receivables
15906000
Annuals > 2 > balance Sheet > inventories
4000
Annuals > 2 > balance Sheet > total Current Assets
158459000
Annuals > 2 > balance Sheet > property Plant Equipment
8210000
Annuals > 2 > balance Sheet > total Assets
215540000
Annuals > 2 > balance Sheet > payables
8613000
Annuals > 2 > balance Sheet > short Term Debt
5080000
Annuals > 2 > balance Sheet > long Term Debt
70195000
Annuals > 2 > balance Sheet > total Liabilities
121012000
Annuals > 2 > balance Sheet > equity
94528000
Annuals > 2 > cash Flow > net Income
-23719000
Annuals > 2 > cash Flow > depreciation
1832000
Annuals > 2 > cash Flow > change In Working Capital
-54791000
Annuals > 2 > cash Flow > cash From Operations
-72638000
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
-46266000
Annuals > 2 > cash Flow > cash From Financing
-3786000
Annuals > 2 > cash Flow > net Change In Cash
-122755000
Annuals > 2 > ratios > PE
-0.4775140025143166
Annuals > 2 > ratios > PB
2.7851203960731215
Annuals > 2 > ratios > ROE
-25.093094109681786
Annuals > 2 > ratios > ROA
-11.004917880671801
Annuals > 2 > ratios > FCF
-72638000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-3.5968308987373114
Annuals > 2 > health Score
25
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
80069000
Annuals > 3 > income Statement > cost Of Revenue
161000
Annuals > 3 > income Statement > gross Profit
79908000
Annuals > 3 > income Statement > operating Expenses
53540000
Annuals > 3 > income Statement > operating Income
31816000
Annuals > 3 > income Statement > interest Expense
4955000
Annuals > 3 > income Statement > pretax Income
69474000
Annuals > 3 > income Statement > net Income
67259000
Annuals > 3 > income Statement > eps
1.2093976811513523
Annuals > 3 > income Statement > dividends Per Share
0
Annuals > 3 > income Statement > shares Outstanding
55613634
Annuals > 3 > income Statement > income Tax Expense
2215000
Annuals > 3 > income Statement > EBITDA
34906000
Annuals > 3 > income Statement > operating Margin
39.73572793465635
Annuals > 3 > income Statement > total Other Income Expense Net
37658000
Annuals > 3 > balance Sheet > cash
258756000
Annuals > 3 > balance Sheet > short Term Investments
0
Annuals > 3 > balance Sheet > receivables
7236000
Annuals > 3 > balance Sheet > inventories
4000
Annuals > 3 > balance Sheet > total Current Assets
268097000
Annuals > 3 > balance Sheet > property Plant Equipment
9015000
Annuals > 3 > balance Sheet > total Assets
281720000
Annuals > 3 > balance Sheet > payables
12304000
Annuals > 3 > balance Sheet > short Term Debt
2187000
Annuals > 3 > balance Sheet > long Term Debt
72047000
Annuals > 3 > balance Sheet > total Liabilities
162623000
Annuals > 3 > balance Sheet > equity
119097000
Annuals > 3 > cash Flow > net Income
67259000
Annuals > 3 > cash Flow > depreciation
2742000
Annuals > 3 > cash Flow > change In Working Capital
59679000
Annuals > 3 > cash Flow > cash From Operations
99915000
Annuals > 3 > cash Flow > capital Expenditures
537000
Annuals > 3 > cash Flow > cash From Investing
-3377000
Annuals > 3 > cash Flow > cash From Financing
-8916000
Annuals > 3 > cash Flow > net Change In Cash
87727000
Annuals > 3 > ratios > PE
1.2093976811513523
Annuals > 3 > ratios > PB
2.4748924003123505
Annuals > 3 > ratios > ROE
56.474134528997375
Annuals > 3 > ratios > ROA
23.87441431208292
Annuals > 3 > ratios > FCF
99378000
Annuals > 3 > ratios > Piotroski FScore
4
Annuals > 3 > ratios > fcf Percent
1.2411545042400929
Annuals > 3 > health Score
84
Valuation > metrics > PE
-0.19998069692148035
Valuation > metrics > PB
5.028576507470651
Valuation > final Score
29.714234925293486
Valuation > verdict
67.6% Overvalued
Profitability > metrics > ROE
-18.973928952584235
Profitability > metrics > ROA
-6.40549704366624
Profitability > metrics > Net Margin
-0.2801744758688617
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
3.1294976368348832
Risk > metrics > Interest Coverage
0.006873473817491182
Risk > final Score
6
Risk > verdict
High
Liquidity > metrics > Current Ratio
4.910558574497662
Liquidity > metrics > Quick Ratio
4.910432200176924
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
41.97720939269618
Prev Valuations > 1
41.97720939269618
Prev Valuations > 2
67.14111211651243
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
100
Prev Risks > 0
-17
Prev Risks > 1
-23
Prev Risks > 2
70
Prev Liquidities > 0
81
Prev Liquidities > 1
81
Prev Liquidities > 2
100
Updated At
2025-12-16T22:43:58.116Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-20
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-09-22
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.2
Earnings History > 1 > eps Estimate
0.1141
Earnings History > 1 > eps Difference
-0.3141
Earnings History > 1 > surprise Percent
-275.2848
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-04-29
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.61
Earnings History > 2 > eps Estimate
-0.4588
Earnings History > 2 > eps Difference
-0.1512
Earnings History > 2 > surprise Percent
-32.9555
Earnings History > 3 > period
2024-09-30
Earnings History > 3 > report Date
2024-11-07
Earnings History > 3 > date
2024-09-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
0
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-06-30
Earnings History > 4 > report Date
2024-09-19
Earnings History > 4 > date
2024-06-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
0.53
Earnings History > 4 > eps Estimate
0.3365
Earnings History > 4 > eps Difference
0.1935
Earnings History > 4 > surprise Percent
57.5037
Earnings History > 5 > period
2024-03-31
Earnings History > 5 > report Date
2024-05-14
Earnings History > 5 > date
2024-03-31
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
EUR
Earnings History > 5 > eps Actual
-0.1731
Earnings History > 5 > eps Estimate
-0.17
Earnings History > 5 > eps Difference
-0.0031
Earnings History > 5 > surprise Percent
-1.8235
Earnings History > 6 > period
2023-09-30
Earnings History > 6 > report Date
2023-11-09
Earnings History > 6 > date
2023-09-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
EUR
Earnings History > 6 > eps Actual
0
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2023-06-30
Earnings History > 7 > report Date
2023-09-20
Earnings History > 7 > date
2023-06-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
EUR
Earnings History > 7 > eps Actual
0
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-03-31
Earnings History > 8 > report Date
2023-04-13
Earnings History > 8 > date
2023-03-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
EUR
Earnings History > 8 > eps Actual
0
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2022-12-31
Earnings History > 9 > report Date
2023-02-07
Earnings History > 9 > date
2022-12-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
EUR
Earnings History > 9 > eps Actual
0
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2022-09-30
Earnings History > 10 > report Date
2022-11-10
Earnings History > 10 > date
2022-09-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
EUR
Earnings History > 10 > eps Actual
0
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2022-06-30
Earnings History > 11 > report Date
2022-09-28
Earnings History > 11 > date
2022-06-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
EUR
Earnings History > 11 > eps Actual
0
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-03-31
Earnings History > 12 > report Date
2022-04-07
Earnings History > 12 > date
2022-03-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
EUR
Earnings History > 12 > eps Actual
0
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2021-09-30
Earnings History > 13 > report Date
2021-11-08
Earnings History > 13 > date
2021-09-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
EUR
Earnings History > 13 > eps Actual
0
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2021-06-30
Earnings History > 14 > report Date
2021-09-30
Earnings History > 14 > date
2021-06-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
EUR
Earnings History > 14 > eps Actual
0
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2021-03-31
Earnings History > 15 > report Date
2021-04-01
Earnings History > 15 > date
2021-03-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
EUR
Earnings History > 15 > eps Actual
0.1127
Earnings History > 15 > eps Estimate
-0.24
Earnings History > 15 > eps Difference
0.3527
Earnings History > 15 > surprise Percent
146.9583
Earnings History > 16 > period
2020-12-31
Earnings History > 16 > report Date
2021-03-31
Earnings History > 16 > date
2020-12-31
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
EUR
Earnings History > 16 > eps Actual
0.1114
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
0.1114
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2020-09-30
Earnings History > 17 > report Date
2020-11-16
Earnings History > 17 > date
2020-09-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
EUR
Earnings History > 17 > eps Actual
-0.7578
Earnings History > 17 > eps Estimate
-0.3
Earnings History > 17 > eps Difference
-0.4578
Earnings History > 17 > surprise Percent
-152.6
Earnings History > 18 > period
2020-06-30
Earnings History > 18 > report Date
2020-09-30
Earnings History > 18 > date
2020-06-30
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
EUR
Earnings History > 18 > eps Actual
-0.44
Earnings History > 18 > eps Estimate
-0.48
Earnings History > 18 > eps Difference
0.04
Earnings History > 18 > surprise Percent
8.3333
Earnings History > 19 > period
2020-03-31
Earnings History > 19 > report Date
2020-04-08
Earnings History > 19 > date
2020-03-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
EUR
Earnings History > 19 > eps Actual
-0.6563
Earnings History > 19 > eps Estimate
-0.88
Earnings History > 19 > eps Difference
0.2237
Earnings History > 19 > surprise Percent
25.4205
Earnings History > 20 > period
2019-09-30
Earnings History > 20 > report Date
2019-10-01
Earnings History > 20 > date
2019-09-30
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
EUR
Earnings History > 20 > eps Actual
-0.77
Earnings History > 20 > eps Estimate
-0.83
Earnings History > 20 > eps Difference
0.06
Earnings History > 20 > surprise Percent
7.2289
Earnings History > 21 > period
2019-03-31
Earnings History > 21 > report Date
2019-04-30
Earnings History > 21 > date
2019-03-31
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
EUR
Earnings History > 21 > eps Actual
-0.7353
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
-0.7353
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2018-12-31
Earnings History > 22 > report Date
2019-02-03
Earnings History > 22 > date
2018-12-31
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
EUR
Earnings History > 22 > eps Actual
-1.31
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
-1.31
Earnings History > 22 > surprise Percent
-
Genfit S.A., a late-stage biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company develops Elafibranor, which is in Phase III clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagnosis of nonalcoholic steatohepatitis (NASH) and fibrosis; VS-01 for the treatment of Urea Cycle Disorder (UCD) and Organic Acidemia Disorder (OAD); GNS561, which is in Phase 1b/2a trial to treat patients with cholangiocarcinoma (CCA); VS-01-ACLF and Nitazoxanide (NTZ), which is in Phase 1 trial to treat acute-on-chronic liver failure, as well as VS-02-HE, which is in preclinical trial for the treatment of Reduction of Hyperammonemia and the Stabilization of Blood Ammonia; CML-022; SRT-015, an ASK1 inhibitor targets the inhibition of cellular apoptosis, inflammation, and fibrosis. The company has a licensing agreement with Labcorp for the commercialization of NASHnext, a blood-based molecular diagnostic test; and Genoscience Pharma to develop and commercialize the investigational treatment GNS561 for CCA. The company was incorporated in 1999 and is headquartered in Loos, France.
Stock Price
$ 0.00
0% increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AAug Chart Watch: Will Prudential Financial Inc. stock outperform Dow Jones index - 2025 Growth vs Value & Entry Point Confirmation Alerts Bollywood Helpline
Read more →Retail Trends: Will CASY stock outperform Nasdaq index - July 2025 Action & Real-Time Sentiment Analysis moha.gov.vn
Read more →Showing 2 of 10
(Last Updated 2025-06-30)
Rating:
STRONG BUY
Target Price:
$7.3857
Analyst Picks
Strong Buy
1
Buy
0
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.12% of the total shares of Genfit S.A.
1.
Morgan Stanley - Brokerage Accounts(0.0548%)
since
2025/06/30
2.
Citadel Advisors Llc(0.0375%)
since
2025/06/30
3.
Optiver Holding B.V.(0.0093%)
since
2025/06/30
4.
UBS Group AG(0.0082%)
since
2025/06/30
5.
Fidelity Nasdaq Composite Index(0.0064%)
since
2025/07/31
6.
Advisor Group Holdings, Inc.(0.0004%)
since
2025/06/30
7.
Principal Securities Inc(0%)
since
2025/06/30
8.
Rhumbline Advisers(0%)
since
2025/06/30
9.
Bank of America Corp(0%)
since
2025/06/30
10.
Millennium Management LLC(0%)
since
2025/06/30
11.
OLD MISSION CAPITAL LLC.(0%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
0
EPS Estimate
0
EPS Difference
0
Surprise Percent
null%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.